Design Better Clinical Trials

Trials.ai leverages artificial intelligence to optimize clinical trials for speed and success

Because patients don’t have time to wait!

CHECK US OUT IN THE NEWS

Bring New Treatments to Patients, Faster!

Trials.ai leverages massive amounts of data that empowers research teams with insights and recommendations to make decisions about how to design their trials. Think of it as the best second opinion you’ve ever had. The results are optimized trials that ultimately enable new treatments to reach patients faster – all through a lens of patient centricity that is powered by our Patient Burden Index TM.   

Read the latest published paper by our Chief Scientist, Dr. David Fogel

Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A Review

AI For Trial Design

We’re leveraging Artificial Intelligence (NLP, NLU, Machine Learning, and Deep Learning) to help Life Science organizations optimize their protocol designs. Our system learns from all kinds of sources, like genomic data, past clinical trials, journal articles and more to help Life Science organizations build their best studies.

Success Stories

“Although my team is small, Trials.ai has enabled us to conduct multiple studies by reducing our administrative duties by about 33% & reduced data errors by 20%. It would have been impossible to run our trials had we not switched from our previous system to Trials.ai”

Dr. Irene Su – Moores Cancer Center

Principal Investigator, youngcancersurvivor.com

Alex Arrow

“Trials.ai alerted me to threats in my protocol that could have been a real problem. Once the protocol was optimized and the workflow was in place – Trials.ai gave us total clarity into our trials’ health which included site performance metrics. Armed with that real-time information, we were able to make smart business decisions based on the health of our study.”

Dr. Alex Arrow – Zelegent

CEO, zelegent.com